Jose Berrios, the Toronto Blue Jays right-handed pitcher, will miss the remainder of the season after undergoing Tommy John surgery on Wednesday. The surgery, which involves elbow ligament replacement, typically requires a recovery period of at least one year. Dr. Keith Meister performed the procedure, which also included an evaluation for potential ligament damage following the discovery of a stress fracture in Berrios’s elbow. The 31-year-old has not pitched in the majors this season after elbow inflammation was detected during an MRI while he was preparing for the World Baseball Classic. Despite four rehab starts at Triple-A Buffalo, he experienced ongoing discomfort, leading to the surgery. Berrios signed a seven-year, $131 million contract extension with the Blue Jays in November 2021, which runs through 2028. Last season, he recorded a 9-5 record with a 4.17 ERA in 31 appearances and missed the postseason due to elbow issues.
Why It Matters
Jose Berrios’s surgery is significant as it highlights the increasing prevalence of Tommy John surgery among pitchers, which has become a common procedure in Major League Baseball due to the physical demands of the sport. Berrios’s absence will impact the Blue Jays’ pitching rotation, particularly as they navigate the remainder of the season without a key player. Since making his major league debut in 2016, Berrios has established himself as a reliable pitcher, but injuries have affected his performance and availability, limiting his contributions to the team. The long recovery process following Tommy John surgery may also raise questions about his future performance and the overall health of pitchers in the league.
Want More Context? 🔎
